## Abstract ## Background Suicidality is a health concern in patients with schizophrenia. We examined the hypotheses: (1) Middle aged and older patients with schizophrenia, depressive symptoms and suicidality would exhibit worse quality of life and worse everyday functioning, social skills and med
Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia
β Scribed by S. Mohamed; M. W. Bondi; J. W. Kasckow; S. Golshan; D. V. Jeste
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 87 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1528
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Alcohol abuse and dependence have important clinical implications for managing patients with schizophrenia. Alcoholism in schizophrenia patients can interfere with the course and prognosis of the schizophrenic illness.
Objective
The purpose of the present study was to compare the cognitive status, symptom profile and quality of life of middle aged and older patients (>44 years old) with schizophrenia and alcohol abuse/dependence vs those without alcohol abuse/dependence. We initially hypothesized that more males in this age group with schizophrenia would exhibit alcoholism. We also examined the characteristics of the 45β54 year age group with those of theββ₯β55 year old group and hypothesized that comorbidity with alcohol would be associated with worse cognition and quality of life in later life.
Methods
Data were obtained from a database from the Center for Services and Interventions research at the University of California, San Diego. Patients had diagnoses of schizophrenia or schizoaffective disorder. Data collected included demographic characteristics, cognitive status (tested with the Mattis Dementia Rating Scale learning, the Figural and Story Memory Test of the Wechsler Memory ScaleβRevised and the California Verbal Learning Test [CVLT]). In addition, patients had undergone psychopathologic assessment and were screened for quality of life using the Quality of Well Being scale.
Results
We demonstrated that the older aged patients with alcoholism had worse scores assessing cognition relative to the same aged group without alcoholism. In addition, they had worse cognitive scores relative to the younger group (45β54 year old) with alcoholism. There was no significant difference with regards to quality of life. In addition, more males than females exhibited alcoholism.
Conclusion
The results are consistent with the premise that the higher cognitive function in the younger schizophrenia patients with alcoholism appear to mask the effects of alcohol use on cognition at that age. However, for the older group of schizophrenia patients, the effects of alcohol use on neuropsychological functioning appear to be deleterious. Copyright Β© 2006 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract ## Background Subsyndromal symptoms of depression (SSD) in patients with schizophrenia are common and clinically important. SSRI's appear to be helpful in alleviating depressive symptoms in patients with schizophrenia who have SSD in patients age 40 and greater. It is not known whether
## Abstract ## Objective The relationship of cognitive impairment to functional status in older adults with schizophrenia was investigated. ## Patients Ninetyβthree psychiatric inpatients with schizophrenia between the ages of 65 and 88 years. Two subsets of this sample, consisting of 48 and 24
## Abstract ## Objective The quality of life (QOL) for individuals with schizophrenia is determined by a number of factors, not limited to symptomatology. The current study examined lack of insight as one such factor that may influence subjective QOL or functional capacity. It was hypothesized tha
This study investigated the cardiac responses and pharmacokinetics following the acute and chronic administration of verapamil in 14 middle-aged and elderly patients with ischemic heart disease (age range 42-76 years). There were small significant reductions in heart rate during chronic treatment, b